Does anaesthetic approach for caesarean section with a combination of rocuronium and sugammadex confers any benefit over suxamethonium, rocuronium and neostigmine? A prospective single blinded randomized study.

ŠTOURAČ, Petr, Martina KOSINOVÁ, Dagmar SEIDLOVÁ, Milan ADAMUS, Hana HARAZIM and Tomáš PAVLÍK. Does anaesthetic approach for caesarean section with a combination of rocuronium and sugammadex confers any benefit over suxamethonium, rocuronium and neostigmine? A prospective single blinded randomized study. In Euroanaesthesia 2015. 2015. ISSN 0265-0215.

Basic information

• Original name: Does anaesthetic approach for caesarean section with a combination of rocuronium and sugammadex confers any benefit over suxamethonium, rocuronium and neostigmine? A prospective single blinded randomized study.
• Name in Czech: Může anesteziologický postup s kombinací rokuronia a sugammadexu přinést nějaký benefit u císařského řezu oproti sukcinylcholinu, rokuroniu a neostigminu? Prospektivní jednoduše zaslepená randomizovaná studie.
• Authors: ŠTOURAČ, Petr, Martina KOSINOVÁ, Dagmar SEIDLOVÁ, Milan ADAMUS, Hana HARAZIM and Tomáš PAVLÍK.
• Edition: Euroanaesthesia 2015, 2015.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30000 3. Medical and Health Sciences
• Country of publisher: Czech Republic
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 3.634
• Organization unit: Faculty of Medicine
• ISSN: 0265-0215
• Keywords (in Czech): císařský řez; rokuronium; sugamamadex
• Keywords in English: Cesarean Section; rocuronium; sugammadex
• Tags: International impact, Reviewed

Abstract

Rocuronium for caesarean section (CS) under general anaesthesia (GA) is now an alternative to suxamethonium for rapid sequence induction (RSI) owing to sugammadex. However, there are no large well-controlled studies that have been done in this setting. The aim of this study was to find out if a combination of rocuronium and sugammadex confers any benefit over suxamethonium, rocuronium and neostigmine in GA for CS.

Abstract (in Czech)

Rokuronium pro císařský řez (CS) v celkové anestezii (GA) je nyní alternativou k sukcinylcholinu pro bleskový úvod (RSI) z důvodu dostupnosti sugammadexu. Nicméně neexistují žádné velké studie, které by byly provedeny v těchto podmínkách.Cílem této studie bylo zjistit, zda kombinace rokuronia a sugammadexu přináší nějakou výhodu oproti sukcinylcholinu, rokuroniu a neostigminu u císařského řezu.